Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Watson

Showing results (841-850 of 883) with videos related to

Pageof 89
Sort By:
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 19, 2024
A case of swine influenza A(H1N2)v in England, November 2023Jade Cogdale, Beatrix Kele, Richard Myers, et al.
The Lancet. Infectious Diseases|October 17, 2017
Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety reportPierre-Stéphane Gsell, Anton Camacho, Adam J Kucharski, et al.
Influenza and Other Respiratory Viruses|May 14, 2024
End of 2022/23 Season Influenza Vaccine Effectiveness in Primary Care in Great BritainHeather J Whitaker, Naoma Willam, Simon Cottrell, et al.
The Lancet Regional Health. Europe|May 8, 2026
Bivalent RSV prefusion vaccine effectiveness against hospitalisation in older adults: meta-analysis of case-control studies in England, Wales, Scotland, and Northern IrelandMagda Bucholc, Safraj Shahul Hameed, Simon Cottrell, et al.
Virus Evolution|March 17, 2023
Quantifying the value of viral genomics when inferring who infected whom in the 2014-16 Ebola virus outbreak in GuineaAlexis Robert, Joseph Tsui Lok Hei, Conall H Watson, et al.
Biopreservation and Biobanking|May 22, 2014
Specimen quality evaluation in Canadian biobanks participating in the COEUR repositoryCécile Le Page, Martin Köbel, Manon de Ladurantaye, et al.
Lancet (London, England)|August 8, 2015
Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trialAna Maria Henao-Restrepo, Ira M Longini, Matthias Egger, et al.
Lancet (London, England)|December 27, 2016
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)Ana Maria Henao-Restrepo, Anton Camacho, Ira M Longini, et al.
BMC Medicine|November 7, 2024
rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l'essai proches)Conall H Watson, Pierre-Stéphane Gsell, Yper Hall, et al.
The Lancet. Global Health|December 14, 2016
Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling studyDaouda Sissoko, Sophie Duraffour, Romy Kerber, et al.
Pageof 89

Showing results (841-850 of 883) with videos related to

Sort By:
Pageof 89
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 19, 2024
A case of swine influenza A(H1N2)v in England, November 2023Jade Cogdale, Beatrix Kele, Richard Myers, et al.
The Lancet. Infectious Diseases|October 17, 2017
Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety reportPierre-Stéphane Gsell, Anton Camacho, Adam J Kucharski, et al.
Influenza and Other Respiratory Viruses|May 14, 2024
End of 2022/23 Season Influenza Vaccine Effectiveness in Primary Care in Great BritainHeather J Whitaker, Naoma Willam, Simon Cottrell, et al.
The Lancet Regional Health. Europe|May 8, 2026
Bivalent RSV prefusion vaccine effectiveness against hospitalisation in older adults: meta-analysis of case-control studies in England, Wales, Scotland, and Northern IrelandMagda Bucholc, Safraj Shahul Hameed, Simon Cottrell, et al.
Virus Evolution|March 17, 2023
Quantifying the value of viral genomics when inferring who infected whom in the 2014-16 Ebola virus outbreak in GuineaAlexis Robert, Joseph Tsui Lok Hei, Conall H Watson, et al.
Biopreservation and Biobanking|May 22, 2014
Specimen quality evaluation in Canadian biobanks participating in the COEUR repositoryCécile Le Page, Martin Köbel, Manon de Ladurantaye, et al.
Lancet (London, England)|August 8, 2015
Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trialAna Maria Henao-Restrepo, Ira M Longini, Matthias Egger, et al.
Lancet (London, England)|December 27, 2016
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)Ana Maria Henao-Restrepo, Anton Camacho, Ira M Longini, et al.
BMC Medicine|November 7, 2024
rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l'essai proches)Conall H Watson, Pierre-Stéphane Gsell, Yper Hall, et al.
The Lancet. Global Health|December 14, 2016
Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling studyDaouda Sissoko, Sophie Duraffour, Romy Kerber, et al.
Pageof 89